BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10723345)

  • 1. New approach to vascular access revascularisation: the Hydrolyser Thrombectomy Catheter.
    Martinez JF; Momblanch T; Pallares M; Alonso J; Sanz A; Marti A
    EDTNA ERCA J; 1996; 22(4):26-8. PubMed ID: 10723345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study.
    Elseviers MM; Van Waeleghem JP;
    Nephrol News Issues; 2003 Jul; 17(8):61-4, 66-8, 99. PubMed ID: 12882114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of an effective venopuncture to recirculation.
    Doula M; Doutsiou C; Kokolaki S; Papa V; Arabatzi S; Papathanasiou A; Spaia S; Theodoridis M; Vayionas G
    EDTNA ERCA J; 1996; 22(4):36-8. PubMed ID: 10723349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A teaching tool for managing hemodialysis vascular access failure. Part II.
    Sands JJ
    Nephrol News Issues; 1998 Oct; 12(10):47-52. PubMed ID: 10196956
    [No Abstract]   [Full Text] [Related]  

  • 6. What should nephrologists do to maximize the use of arteriovenous fistulas?
    Nassar GM
    Semin Dial; 2006; 19(3):207-9. PubMed ID: 16689971
    [No Abstract]   [Full Text] [Related]  

  • 7. Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS.
    Saran R; Dykstra DM; Pisoni RL; Akiba T; Akizawa T; Canaud B; Chen K; Piera L; Saito A; Young EW
    Nephrol Dial Transplant; 2004 Sep; 19(9):2334-40. PubMed ID: 15252160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospective monitoring of vascular access in hemodialysis by means of a multidisciplinary team].
    Gruss E; Portolés J; Jiménez P; Hernández T; Rueda JA; del Cerro J; Lasala M; Tato A; Gago MC; Martínez S; Velayos P
    Nefrologia; 2006; 26(6):703-10. PubMed ID: 17227248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous access for patients with chronic kidney disease.
    Saad TF; Vesely TM
    J Vasc Interv Radiol; 2004 Oct; 15(10):1041-5. PubMed ID: 15466788
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].
    García Cortés MJ; Viedma G; Sánchez Perales MC; Borrego FJ; Borrego J; Pérez del Barrio P; Gil Cunquero JM; Liébana A; Pérez Bañasco V
    Nefrologia; 2005; 25(3):307-14. PubMed ID: 16053012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular access thrombosis: etiology and prevention.
    Brattich M
    ANNA J; 1999 Oct; 26(5):537-40. PubMed ID: 10776083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revascularization of occluded haemodialysis fistulae with the Hydrolyser thrombectomy catheter: description of the technique and report of six cases.
    Pattynama PM; van Baalen J; Verburgh CA; van der Pijl JW; Schultze Kool LJ
    Nephrol Dial Transplant; 1995; 10(7):1224-7. PubMed ID: 7478128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patency rates and complications of Exxcel yarn-wrapped polytetrafluoroethylene grafts versus Gore-tex stretch polytetrafluoroethylene grafts: a prospective study.
    Ko PJ; Hsieh HC; Chu JJ; Lin PJ; Liu YH
    Surg Today; 2004; 34(5):409-12. PubMed ID: 15108078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Saran R; Dykstra DM; Wolfe RA; Gillespie B; Held PJ; Young EW;
    Am J Kidney Dis; 2002 Dec; 40(6):1255-63. PubMed ID: 12460045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving arteriovenous fistula cannulation skills.
    Ball LK
    Nephrol Nurs J; 2005; 32(6):611-7; quiz 618. PubMed ID: 16425809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous interventions in dialysis access.
    Gram CH; Trachtenberg JD
    Perspect Vasc Surg Endovasc Ther; 2006 Dec; 18(4):318-21. PubMed ID: 17351199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemoglobin level and vascular access survival in haemodialysis patients.
    Garrancho JM; Kirchgessner J; Arranz M; Klinkner G; Rentero R; Ayala JA; Marcelli D
    Nephrol Dial Transplant; 2005 Nov; 20(11):2453-7. PubMed ID: 16077146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subcutaneous vascular access].
    Heinrich P; Müller JS
    Z Urol Nephrol; 1988 Mar; 81(3):167-71. PubMed ID: 3388996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.